comparemela.com

Latest Breaking News On - Youzhi tong - Page 3 : comparemela.com

Kintor Pharma Announces 2022 Annual Results and Recent Business Progress

SUZHOU, China, March 30, 2023 /PRNewswire/ Kintor Pharmaceutical Limited (Kintor Pharma, HKEX: 9939), a clinical-stage biotechnology company de.

Hong kongJianzhong zhangKintor pharmaUniversity people hospitalRapid progress on global clinical developmentHong kong listed companiesHong kong stock exchangeInnovation companiesInnovative pharmaceutical companiesMeeting of chinese hair research societyKintor pharmaceuticalPrnewswire kintor pharmaceutical limited pharmaPharmaceutical limitedShanghai hong kong stock connectYouzhi tongGlobal clinical development

Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China

/PRNewswire/ Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and.

Kintor pharmaZhang jianzhongYang qinpingPrnewswire kintor pharmaceutical limited pharmaKintor pharmaceuticalUniversity people hospitalHuashan hospital affiliated to fudan universityPharmaceutical limitedProfessor zhang jianzhongPeking university peopleProfessor yang qinpingHuashan hospital affiliatedFudan universityYouzhi tongChief executive officer

Kintor Pharma Announces Positive Top-line U S Phase I Trial Results of GT20029, the World s First Topical Use PROTAC Compound

DJ Kintor Pharma Announces Positive Top-line U.S. Phase I Trial Results of GT20029, the World's First Topical Use PROTAC Compound EQS Newswire / 13/02/2023 / 09:59 UTC+8 Suzhou, February 10, 2023

Kintor pharmaChina national medical products administrationDrug administrationFinancial pressKintor pharmaceuticalKintor pharmaceutical limited pharmaTrial resultsFirst topical usePharmaceutical limitedYouzhi tongChief executive officerFinancial press releaseDow jones newswiresMarcel torney

Kintor Pharma Announces Positive Top-line U S Phase I Trial Results of GT20029, the World s First Topical Use PROTAC Compound

/PRNewswire/ Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and.

Kintor pharmaChina national medical products administrationDrug administrationKintor pharmaceutical limited pharmaKintor pharmaceutical limitedYouzhi tongChief executive officer

Kintor Pharma Announced the Primary Endpoint of Phase II Clinical Study for KX-826 s Treatment of Female Androgenetic Alopecia in China Was Met

DJ Kintor Pharma Announced the Primary Endpoint of Phase II Clinical Study for KX-826's Treatment of Female Androgenetic Alopecia in China Was Met EQS Newswire / 02/12/2022 / 10:34 UTC+8 Kintor

Kintor pharmaJianzhong zhangFinancial pressKintor pharmaceuticalDepartment of dermatologyUniversity people hospitalKintor pharmaceutical limited pharmaPharma announcedPrimary endpointFemale androgenetic alopeciaChina was metPharmaceutical limitedPeking university peopleSavin scaleYouzhi tongChief executive officer

vimarsana © 2020. All Rights Reserved.